TME Pharma provides results of third exercise of warrants Z
1,552 Warrants Z were exercised resulting in the issuance of 1,940 new ordinary shares Outstanding 2,811,080 Warrants Z…
Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines
Bavarian Nordic A/S (OMX: BAVA) today announced an agreement with UNICEF for the supply of 1 million doses of the MVA-BN…
Bavarian Nordic Awarded USD 63 Million from the U.S. Government for Production and Supply of Additional Smallpox/Mpox Vaccines
Contract will further strengthen the U.S, bulk vaccine inventory and secure additional freeze-dried doses Deliveries pla…
Produktneuheit: LiquiDry Flüssigkeitsabsorber
Die ThoMar OHG erweitert ihr Sortiment um Flüssigkeitsabsorber und stellt das neue LiquiDry-Produkt vor. Diese innovativ…
Heidelberg Pharma gibt die Präsentation neuer klinischer Daten des führenden ATAC-Kandidaten HDP-101 auf der International Myeloma Society-Jahrestagung 2024 bekannt
Die Heidelberg Pharma AG (FWB: HPHA), ein klinischer Entwickler von innovativen Antikörper-Wirkstoff-Konjugaten (Antibod…
TME Pharma Announces Acceptance of the NCI’s Abstract on NOX-A12 in Glioblastoma ior Presentation at the SNO 2024 Annual Meeting
Presentation will feature the results of the work conducted by the National Cancer Institute on inhibition of CXCL12 Res…
Gavi Signs Agreement with Bavarian Nordic to Rapidly Secure 500,000 Doses of Mpox Vaccines for Africa
The advance purchase agreement (APA) will be funded by Gavi’s First Response Fund, a mechanism created after the COVID-1…
PharmaXR: XR- und KI-Technologien transformiert Schulungsprozesse in der Pharmaindustrie
Das vom Bundesministerium für Bildung und Forschung geförderte Forschungsprojekt PharmaXR (Laufzeit: August 2024 - Juli…
TME Pharma Announces Oral Presentation at Esmo Congress 2024 with Updated Results from Nox-A12 Gloria Phase 1/2 Trial in Glioblastoma
Presentation highlights data from the combined inhibition of angiogenesis and vasculogenesis with NOX-A12 and bevacizuma…
Bavarian Nordic Receives WHO Prequalification for Mpox Vaccine
First mpox vaccine to obtain prequalification by the WHO Approval will help accelerate access to the vaccine for all…